151 related articles for article (PubMed ID: 21718815)
21. Breast cancer resistance protein (Bcrp1/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milk.
van Herwaarden AE; Wagenaar E; Karnekamp B; Merino G; Jonker JW; Schinkel AH
Carcinogenesis; 2006 Jan; 27(1):123-30. PubMed ID: 16000399
[TBL] [Abstract][Full Text] [Related]
22. Transport of anthelmintic benzimidazole drugs by breast cancer resistance protein (BCRP/ABCG2).
Merino G; Jonker JW; Wagenaar E; Pulido MM; Molina AJ; Alvarez AI; Schinkel AH
Drug Metab Dispos; 2005 May; 33(5):614-8. PubMed ID: 15703302
[TBL] [Abstract][Full Text] [Related]
23. Glucocorticoid regulation of placental breast cancer resistance protein (Bcrp1) in the mouse.
Petropoulos S; Gibb W; Matthews SG
Reprod Sci; 2011 Jul; 18(7):631-9. PubMed ID: 21602547
[TBL] [Abstract][Full Text] [Related]
24. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan.
Jonker JW; Smit JW; Brinkhuis RF; Maliepaard M; Beijnen JH; Schellens JH; Schinkel AH
J Natl Cancer Inst; 2000 Oct; 92(20):1651-6. PubMed ID: 11036110
[TBL] [Abstract][Full Text] [Related]
25. Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene.
Ee PL; Kamalakaran S; Tonetti D; He X; Ross DD; Beck WT
Cancer Res; 2004 Feb; 64(4):1247-51. PubMed ID: 14973083
[TBL] [Abstract][Full Text] [Related]
26. Association of breast cancer resistance protein/ABCG2 phenotypes and novel promoter and intron 1 single nucleotide polymorphisms.
Poonkuzhali B; Lamba J; Strom S; Sparreboom A; Thummel K; Watkins P; Schuetz E
Drug Metab Dispos; 2008 Apr; 36(4):780-95. PubMed ID: 18180275
[TBL] [Abstract][Full Text] [Related]
27. Analysis of molecular mechanisms controlling neuroendocrine cell specific transcription of the chromogranin A gene.
Canaff L; Bevan S; Wheeler DG; Mouland AJ; Rehfuss RP; White JH; Hendy GN
Endocrinology; 1998 Mar; 139(3):1184-96. PubMed ID: 9492053
[TBL] [Abstract][Full Text] [Related]
28. P-glycoprotein (MDR1/ABCB1) and breast cancer resistance protein (BCRP/ABCG2) restrict brain accumulation of the JAK1/2 inhibitor, CYT387.
Durmus S; Xu N; Sparidans RW; Wagenaar E; Beijnen JH; Schinkel AH
Pharmacol Res; 2013 Oct; 76():9-16. PubMed ID: 23827160
[TBL] [Abstract][Full Text] [Related]
29. Functional characterization of the promoter of human kinetochore protein HEC1: novel link between regulation of the cell cycle protein and CREB family transcription factors.
Cheng L; Li L; Qiao X; Liu J; Yao X
Biochim Biophys Acta; 2007; 1769(9-10):593-602. PubMed ID: 17822787
[TBL] [Abstract][Full Text] [Related]
30. Role of STAT5 and epigenetics in lactation-associated upregulation of multidrug transporter ABCG2 in the mammary gland.
Wu AM; Yang M; Dalvi P; Turinsky AL; Wang W; Butcher D; Egan SE; Weksberg R; Harper PA; Ito S
Am J Physiol Endocrinol Metab; 2014 Oct; 307(7):E596-610. PubMed ID: 25117410
[TBL] [Abstract][Full Text] [Related]
31. Real-time quantitative polymerase chain reaction for BCRP, MDR1, and MRP1 mRNA levels in lymphocytes and monocytes.
Moon YJ; Zhang S; Morris ME
Acta Haematol; 2007; 118(3):169-75. PubMed ID: 17911978
[TBL] [Abstract][Full Text] [Related]
32. Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C.
Allen JD; van Loevezijn A; Lakhai JM; van der Valk M; van Tellingen O; Reid G; Schellens JH; Koomen GJ; Schinkel AH
Mol Cancer Ther; 2002 Apr; 1(6):417-25. PubMed ID: 12477054
[TBL] [Abstract][Full Text] [Related]
33. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells.
Kim M; Turnquist H; Jackson J; Sgagias M; Yan Y; Gong M; Dean M; Sharp JG; Cowan K
Clin Cancer Res; 2002 Jan; 8(1):22-8. PubMed ID: 11801536
[TBL] [Abstract][Full Text] [Related]
34. Expression of ABCG2 (BCRP) is regulated by Nrf2 in cancer cells that confers side population and chemoresistance phenotype.
Singh A; Wu H; Zhang P; Happel C; Ma J; Biswal S
Mol Cancer Ther; 2010 Aug; 9(8):2365-76. PubMed ID: 20682644
[TBL] [Abstract][Full Text] [Related]
35. Proinflammatory cytokines enhance estrogen-dependent expression of the multidrug transporter gene ABCG2 through estrogen receptor and NF{kappa}B cooperativity at adjacent response elements.
Pradhan M; Bembinster LA; Baumgarten SC; Frasor J
J Biol Chem; 2010 Oct; 285(41):31100-6. PubMed ID: 20705611
[TBL] [Abstract][Full Text] [Related]
36. Aryl hydrocarbon receptor is a transcriptional activator of the human breast cancer resistance protein (BCRP/ABCG2).
Tan KP; Wang B; Yang M; Boutros PC; Macaulay J; Xu H; Chuang AI; Kosuge K; Yamamoto M; Takahashi S; Wu AM; Ross DD; Harper PA; Ito S
Mol Pharmacol; 2010 Aug; 78(2):175-85. PubMed ID: 20460431
[TBL] [Abstract][Full Text] [Related]
37. Quantitative proteomics of transporter expression in brain capillary endothelial cells isolated from P-glycoprotein (P-gp), breast cancer resistance protein (Bcrp), and P-gp/Bcrp knockout mice.
Agarwal S; Uchida Y; Mittapalli RK; Sane R; Terasaki T; Elmquist WF
Drug Metab Dispos; 2012 Jun; 40(6):1164-9. PubMed ID: 22401960
[TBL] [Abstract][Full Text] [Related]
38. Side population cells and Bcrp1 expression in lung.
Summer R; Kotton DN; Sun X; Ma B; Fitzsimmons K; Fine A
Am J Physiol Lung Cell Mol Physiol; 2003 Jul; 285(1):L97-104. PubMed ID: 12626330
[TBL] [Abstract][Full Text] [Related]
39. Identification of the cAMP-responsive enhancer of the murine ABCA1 gene: requirement for CREB1 and STAT3/4 elements.
Le Goff W; Zheng P; Brubaker G; Smith JD
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):527-33. PubMed ID: 16373613
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells.
Pan YZ; Morris ME; Yu AM
Mol Pharmacol; 2009 Jun; 75(6):1374-9. PubMed ID: 19270061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
